NEUP
Price
$3.20
Change
-$0.02 (-0.62%)
Updated
Jan 10 closing price
Capitalization
11.25B
38 days until earnings call
SLNO
Price
$43.11
Change
-$1.41 (-3.17%)
Updated
Jan 10 closing price
Capitalization
1.86B
71 days until earnings call
Ad is loading...

NEUP vs SLNO

Header iconNEUP vs SLNO Comparison
Open Charts NEUP vs SLNOBanner chart's image
Neuphoria Therapeutics
Price$3.20
Change-$0.02 (-0.62%)
Volume$43.75K
Capitalization11.25B
Soleno Therapeutics
Price$43.11
Change-$1.41 (-3.17%)
Volume$790.43K
Capitalization1.86B
NEUP vs SLNO Comparison Chart
Loading...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEUP vs. SLNO commentary
Jan 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEUP is a Hold and SLNO is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 13, 2025
Stock price -- (NEUP: $3.20 vs. SLNO: $43.11)
Brand notoriety: NEUP and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NEUP: 20% vs. SLNO: 123%
Market capitalization -- NEUP: $11.25B vs. SLNO: $1.86B
NEUP [@Biotechnology] is valued at $11.25B. SLNO’s [@Biotechnology] market capitalization is $1.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $387.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEUP’s FA Score shows that 0 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • NEUP’s FA Score: 0 green, 5 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, SLNO is a better buy in the long-term than NEUP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEUP’s TA Score shows that 4 TA indicator(s) are bullish while SLNO’s TA Score has 3 bullish TA indicator(s).

  • NEUP’s TA Score: 4 bullish, 5 bearish.
  • SLNO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both NEUP and SLNO are a bad buy in the short-term.

Price Growth

NEUP (@Biotechnology) experienced а -5.88% price change this week, while SLNO (@Biotechnology) price change was -7.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.26%. For the same industry, the average monthly price growth was -0.61%, and the average quarterly price growth was -4.84%.

Reported Earning Dates

NEUP is expected to report earnings on Feb 20, 2025.

SLNO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-6.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEUP($11.2B) has a higher market cap than SLNO($1.86B). SLNO YTD gains are higher at: -4.093 vs. NEUP (-6.706). NEUP has higher annual earnings (EBITDA): -15.23M vs. SLNO (-136.5M). SLNO has more cash in the bank: 257M vs. NEUP (12.1M). NEUP has less debt than SLNO: NEUP (254K) vs SLNO (3.03M). NEUP (0) and SLNO (0) have equivalent revenues.
NEUPSLNONEUP / SLNO
Capitalization11.2B1.86B602%
EBITDA-15.23M-136.5M11%
Gain YTD-6.706-4.093164%
P/E RatioN/AN/A-
Revenue00-
Total Cash12.1M257M5%
Total Debt254K3.03M8%
FUNDAMENTALS RATINGS
SLNO: Fundamental Ratings
SLNO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NEUPSLNO
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 6 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
90%
Bearish Trend 6 days ago
79%
Momentum
ODDS (%)
Bullish Trend 6 days ago
78%
Bearish Trend 6 days ago
85%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 6 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 21 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
View a ticker or compare two or three
Ad is loading...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UTES67.311.30
+1.97%
Virtus Reaves Utilities ETF
IYE47.010.14
+0.30%
iShares US Energy ETF
TAGG41.49-0.24
-0.57%
T. Rowe Price QM US Bond ETF
SNAV29.77-0.45
-1.48%
Mohr Sector Nav ETF
VEA47.53-0.72
-1.49%
Vanguard FTSE Developed Markets ETF

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with SYBX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then SYBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
-0.62%
SYBX - NEUP
64%
Loosely correlated
-1.82%
BRNS - NEUP
50%
Loosely correlated
-9.65%
ENSC - NEUP
31%
Poorly correlated
-5.43%
SLNO - NEUP
27%
Poorly correlated
-3.17%
ZVSA - NEUP
25%
Poorly correlated
+24.58%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with BRNS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
-3.17%
BRNS - SLNO
56%
Loosely correlated
-9.65%
KANT - SLNO
45%
Loosely correlated
N/A
XENE - SLNO
42%
Loosely correlated
-2.88%
KYMR - SLNO
40%
Loosely correlated
-5.80%
ACLX - SLNO
40%
Loosely correlated
-4.40%
More